Two drugs may revolutionize treatment of hepatitis C
Wednesday, March 30, 2011 - 20:00
in Health & Medicine
Boceprevir and telaprevir nearly doubled the number of patients who were able to suppress the virus. They also boosted the odds of controlling the virus among those who did not respond to initial therapy or had a relapse.Two experimental drugs promise to transform hepatitis C from a debilitating liver disease into a manageable condition for a majority of patients, researchers said Wednesday.